Dabur India Ltd (DIL) has informed BSE that the Board of Directors of the Company at its meeting held on October 26, 2009, inter alia, has considered and approved the Scheme for Amalgamation of Fem Care Pharma Ltd. ('FCPL or Transferor Company') with DIL as per terms and conditions mentioned in the Scheme of Amalgamation ('the Scheme') under the provisions of Sections 391 to 394 of the Companies Act, 1956. The salient Features of the Scheme are as under: 1. The Appointed Date for merger under the Scheme is April 01, 2009. 2. In consideration of the Amalgamation of FCPL with DIL, the Company shall allot 5 (five) Equity Share(s) of the face value of Re. 1 each credited as fully paid-up, for every 1 (one) Equity Share of the face value of Rs. 10 each held by the shareholders of FCPL. 3. As a result of the merger, the portion of share capital of FCPL held by DIL (i.e., 32,52,476 equity shares) shall stand cancelled and there would be no issuance of shares by the DIL in relation to such shares. 4. The Scheme is subject to requisite consent / approval of the shareholders, lenders, creditors of the Company, and sanction of the Hon'ble High Court of Judicature at Delhi and Hon'ble High Court of Judicature at Bombay and the permission or approval of any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme. Fem Care Pharma Ltd has informed BSE that by an Order made on the December 04, 2009, the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of Fem Care Pharma Ltd, the Applicant Company, will be held on January 14, 2010, for the purpose of considering and, if thought fit, approving with or without modification(s), the proposed arrangement embodied in the Scheme of Amalgamation of Fem Care Pharma Ltd. ('the Transferor Company') with Dabur India Ltd. ('the Transferee Company') and their Respective Shareholders. (As Per BSE Announcement Website dated on 17.12.2009) Dabur India Ltd has informed BSE that by an Order made on the December 22, 2009, the Hon'ble High Court of Judicature at Delhi has directed that a meeting of the Equity Shareholders and Unsecured Creditors of Dabur India Ltd., the Applicant Company, shall be held on February 01, 2010, for the purpose of considering and, if thought fit, approving with or without modification(s), the proposed arrangement embodied in the Scheme of Amalgamation of Fern Care Pharma Ltd. ('the Transferor Company') with Dabur India Ltd. ('the Transferee Company') and their Respective Shareholders. (As Per BSE Announcement Dated on 24/12/2009) Dabur India Ltd has informed BSE that pursuant to an Order made on December 22, 2009, Hon'ble High Court has directed that a meeting of the Equity Shareholders & Unsecured Creditors of the Company will be held on February 01, 2010, for the purpose of considering and if thought fit, approving with or without modifications, the amalgamation embodied in the Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. and their respective Shareholders. (As Per BSE Announcement Website dated on 06.01.2010) Fem Care Pharma Ltd has informed BSE that the Members of the Company at the Court Convened Meeting held on January 14, 2010, have unanimously approved the Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. and their respective Shareholders made under the provisions of Sections 391 to 394 and other applicable provisions of the Companies Act, 1956, with effect from April 01, 2009 ('Appointed Date') subject to necessary approvals of Hon'ble High Court of Judicature at Bombay and Delhi and such other authority(ies) as may be required. (As Per BSE Announcement Dated on 15/01/2010) Dabur India Ltd has informed BSE that the equity shareholders and unsecured creditors of the Company at its court convened meetings held on February 01, 2010, unanimously approved the Scheme of Amalgamation of Fem Care Pharma Ltd. ('the Transferor Company') with Dabur India Ltd. ('the Transferee Company') and their respective shareholders. (As Per BSE Announcement Website dated on 17.02.2010) Dabur India Ltd has informed BSE regarding update on Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. and their respective shareholders ('the Scheme') as follows -: By an Order made on February 17, 2010, the Hon'ble High Court of Judicature at Delhi had directed to publish Notice of Petition for next hearing, which has been fixed for April 07, 2010 in newspapers. In accordance therewith Notice of Petition were published on March 11, 2010. (As Per BSE Announcement Website dated on 12.03.2010) Dabur India Ltd has informed BSE that by an Order dated April 19, 2010 the Hon'ble High Court of Judicature at Delhi has sanctioned the Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. and their respective shareholders, from the appointed date of amalgamation being April 01, 2009, subject to sanction of the said scheme in respect of the transferor Company from the court of competent jurisdiction. (As Per BSE Announcement Website dated on 23.04.2010) Fem Care Pharma Ltd has informed BSE that the High Court of Judicature at Bombay has approved the Scheme of Amalgamation of the Company with Dabur India Ltd. under Company scheme petition no. 24 of 2010. (As Per BSE Announcement Dated on 07.06.2010) Fem Care Pharma Ltd has informed BSE that the Order dated May 07, 2010 issued by Hon'ble High Court of Judicature at Bombay (certified true copy issued on June 02, 2010) sanctioning the Scheme of Amalgamation of Fem Care Phama Lid (FEM) with Dabur India Limited (DIL) and their respective shareholders, from the appointed date of amalgamation being April 01, 2009, has become effective on June 18, 2O10 upon filing of the said Order with the Registrar of Companies, Mumbai. Dabur India Ltd has informed BSE that the Order dated April 19, 2010 issued by Hon'ble High Court of Judicature at Delhi (certified true copy issued on June 02, 2010) sanctioning the Scheme of Amalgamation of Fem Care Pharma Ltd (FEM) with Dabur India Ltd (DIL) and their respective shareholders, from the appointed date of amalgamation being April 01, 2009, has become effective on June 18, 2010 upon filing of the said Order with the Registrar of Companies, NCT of Delhi & Haryana. (As Per BSE Announcement Dated on 18.06.2010) Dabur India Ltd (DIL) has informed BSE that June 30, 2010, has been fixed as RECORD DATE for Scheme of Amalgamation of Fem Care Pharma Ltd (FEM) with Dabur India Ltd (DIL), for ascertaining the names of shareholders / Beneficial Owners holding equity shares of FEM who would be entitled for the allotment / issue of equity shares of DIL, as per the Register of Members maintained by FEM Depositories, in the Share Exchange Ratio as provided in the Scheme of Amalgamation i.e. 5 (five) fully paid up equity shares of Re. 1 each of DIL for every 1 (one) fully paid up equity share of Rs. 10 each of FEM. (As Per BSE Announcement Dated on 21.06.2010) SUB. :- Scheme of Amalgamation of Fem Care Pharma Ltd. (Scrip Code 524608) Trading members of the Exchange are hereby informed that, Dabur India Ltd. has fixed the Record Date for the purpose to determine entitlement of shareholders of Fem Care Pharma Ltd. pursuant to the Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. Trading Members are advised not to deal in the equity shares of Fem Care Pharma Ltd. with effect from the under mentioned date. COMPANY NAME CODE Fem Care Pharma Ltd. (524608) RECORD DATE 30/06/2010 PURPOSE The Scheme of Amalgamation: - Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. Dabur India Ltd. shall issue and allot to the shareholders of Fem Care Pharma Ltd. in the ratio of 5 (FIVE) equity shares of Re.1/- each fully paid of Dabur India Ltd. for every 1 (ONE) Equity Share of Rs.10/- each fully paid up held in Fem Care Pharma Ltd. NO DEALINGS FROM 29/06/2010 DR- 064/2010-2011 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated 23.06.2010) Dabur India Ltd has informed BSE that pursuant to the Scheme of Amalgamation of Fem Care Pharma Ltd. with Dabur India Ltd. and their respective shareholders ('the Scheme') as approved by the Hon'ble High Courts of Delhi & Mumbai the Company on July 22, 2010 has issued/ allotted 1384620 (Thirteen lac eighty four thousand six hundred and twenty only) fully paid Equity Shares of the face value of Re. 1 each of Dabur India Ltd., against 276924 (two lac seventy six thousand nine hundred and twenty four) Equity Shares of the face value of Rs. 10 each of Fem Care Pharma Ltd., in the exchange ratio of 5 (Five) Equity Share(s) of the face value of Re. 1 each of Dabur India Ltd. for every 1 (One) Equity Share of the face value of Rs. 10 each of Fem care Pharma Ltd. held as on the record date of June 30, 2010. (As Per BSE Announcement Dated on 22.07.2010)